Psychopharmacology in fragile X syndrome—Present and future

Berry‐Kravis, Elizabeth, Potanos, Kristina·2004·Mental Retardation and Developmental Disabilities Research Reviews
DOI 10.1002/mrdd.20007

Cited by (151)

Items 101–151 of 151

  1. Low-Dose Sertraline Improves Receptive Language in Children with Fragile X Syndrome when Eye Tracking Methodology is used to Measure Treatment Outcome
    Susan Michelle Rivera · 2017 · Journal of Psychology & Clinical Psychiatry
  2. MONOGENIC DISORDERS: AN OVERVIEW.
    Usman Babar · 2017 · International Journal of Advanced Research
  3. Fragile X–Associated Disorders
    Marsha Mailick Seltzer, Jan Steven Greenberg, Leann E. Smith, Audra M. Sterling, Nancy C. Brady, Steven F. Warren, Jinkuk Hong · 2014 · Cambridge University Press eBooks
  4. A review of the use of psychotropic medication to address challenging behaviour in neurodevelopmental disorders
    Maria G. Valdovinos, Claire Epperson, Carissa Johnson · 2023 · International review of neurobiology
  5. Molecular medicine of fragile X syndrome: based on known molecular mechanisms
    Shi-Yu Luo, Lingqian Wu, Ranhui Duan · 2015 · World Journal of Pediatrics
  6. Examining the Specificity of Forms and Functions of Aggressive Behavior in Boys With Fragile X Syndrome
    Tobias C. Britton, Ellen H. Wilkinson, Scott S. Hall · 2020 · American Journal on Intellectual and Developmental Disabilities
  7. The Use of Peptides in the Treatment of Fragile X Syndrome: Challenges and Opportunities
    Alice Romagnoli, Daniele Di Marino · 2021 · Frontiers in Psychiatry
  8. Fragile X Syndrome and Attention-Deficit/Hyperactivity Disorder Symptoms
    Presenter Swapna Deshpande, Discussant Barbara J. Coffey · 2011 · Journal of Child and Adolescent Psychopharmacology
  9. Challenges in Conducting Clinical Trials for Pharmacotherapies in Fragile X Syndrome: Lessons Learned
    Christina M. Harkins, Kelli C. Dominick, Logan K. Wink, Ernest V. Pedapati, Rebecca C. Shaffer, Sarah E. Fitzpatrick, Matthew H. Davenport, John A. Sweeney, Craig A. Erickson · 2017 · Pharmaceutical Medicine
  10. Clinical, molecular, and pharmacological aspects of FMR1 -related disorders
    A. Pugin, Víctor Faùndes, Lorena Santa María, Bianca Curotto, Solange Aliaga, Isabel Salas, Pedro Soto, Pamela Eguiguren Bravo, Melina Pena, María Angélica Alliende · 2016 · Neurología (English Edition)
  11. Cognitive-Adaptive Disabilities
    Joseph L. Calles · 2011 · Pediatric Clinics of North America
  12. Fragile X-Associated Disorders
    Scott M. Summers, Randi Jenssen Hagerman · 2014 · Elsevier eBooks
  13. Fragile X syndrome and associated disorders
    Kim M. Cornish, Kylie M. Gray, Nicole Rinehart · 2010 · Advances in child development and behavior
  14. Prevalence of fragile X syndrome in South Asia, and importance of diagnosis
    Aminath Fazna, Randi Jenssen Hagerman · 2024 · Medical Review
  15. Psychopharmacology of neurobehavioral disorders
    Lindsey N. Mooney, Kelli C. Dominick, Craig A. Erickson · 2019 · Handbook of clinical neurology
  16. Fragile X Syndrome
    Anne Hoffmann, Elizabeth Berry‐Kravis · 2016 · Elsevier eBooks
  17. The first awake simultaneous PET-MR study of an adult with fragile X syndrome: A case report
    Soujanya Gade, Trine Hjørnevik, Jun Hyung Park, Bin Shen, Meng Gu, Jessica Tseng, Daniel A. N. Barbosa, Christoph W. Leuze, Sharon J. Pitteri, Jae Ho Jung et al. · 2021 · Research Square
  18. Chromosomes in the Clinic: The Visual Localization and Analysis of Genetic Disease in the Human Genome
    Andrew J. Hogan · 2013 · Scholarly Commons (University of Pennsylvania)
  19. Therapeutic approaches for the future treatment of Fragile X
    Ana Sastre, Nuria Eugenia Campillo, Carmen Gil, Ana Martı́nez · 2015 · Current Opinion in Behavioral Sciences
  20. Postępy w leczeniu zespołu łamliwego chromosomu X
    Małgorzata Lisik, Aleksander L. Sieroń · 2010 · Neurologia i Neurochirurgia Polska
  21. Treatment of Attention Deficit Hyperactivity Disorder in Children With Medical Comorbidities
    Ann M. Kledzik, David Dunn · 2010 · Psychopharm Review
  22. Reflections on Clinical Trials in Fragile X Syndrome
    Aia Elise Jønch, Sébastien Jacquemont · 2017 · Elsevier eBooks
  23. Medication Management of Fragile X Syndrome
    Craig A. Erickson, Logan K. Wink, Tori L. Schaefer, Rebecca C. Shaffer · 2013 · Springer eBooks
  24. Fragile X Syndrome and Premutation‐Associated Disorders
    Randi Jenssen Hagerman · 2010
  25. mGlu5 as a potential therapeutic target for the treatment of fragile X syndrome
    L. Robertson · 2013 · Bioscience Horizons The International Journal of Student Research
  26. Fragile X Syndrome in China
    Ranhui Duan, Kathryn B. Garber, Peng Jin · 2013 · North American Journal of Medicine and Science
  27. Investigating Therapeutic Strategies for Fragile X Syndrome in Mice
    Aubin Michalon, Lothar Lindemann · 2012 · BioValley monographs
  28. Fragile X Syndrome and X-linked Intellectual Disability
    Kathryn B. Garber, Stephen T. Warren, Jeannie Visootsak · 2013 · Elsevier eBooks
  29. Fragile X Syndrome
    Michele Y. Ono, Faraz Farzin, Randi Jenssen Hagerman · 2008 · Elsevier eBooks
  30. Fragile X Syndrome
    Aaron W. Grossman, William T. Greenough, Elizabeth Berry‐Kravis · 2009 · Elsevier eBooks
  31. Visual Spatial Learning and Memory in Fragile X Syndrome and fmr1 Knockout Mice
    Lindsey S. MacLeod · 2013 · uO Research (University of Ottawa)
  32. Uso de fármacos psicotrópicos en niños con trastornos del desarrollo
    Joseph L. Calles · 2008 · Clínicas pediátricas de Norteamérica
  33. Differentiation of neural stem cells in fragile X syndrome
    Topi Aulis Tervonen · 2008 · Työväentutkimus Vuosikirja
  34. Oral Ascorbic Acid and Alpha-Tocopherol to Reduce Behavioural Problems in Young Patients Affected of Fragile X Syndrome: A Randomized, Double-Blind, Placebo-Controlled Phase II Pilot Trial
    Yolanda de Diego‐Otero, Carolina Quintero-Navarro, Rocío Calvo Medina, Raúl Heredia‐Farfan, Lourdes Sanchez Salido, Elena Lima‐Cabello, A. Higuero-Tapiador, Ilaria Del, Isabel Fernández-Carvajal, Teresa Ferrando-Lucas et al. · 2012 · InTech eBooks
  35. Historical perspectives on the use of therapeutic agents to treat neurodevelopmental disorders
    Kimberly A. Stigler, Craig A. Erickson, David J. Posey, Christopher J. McDougle · 2012 · Cambridge University Press eBooks
  36. Social Behavior in FMR1 KO Mice: a Model of Fragile X Syndrome
    Caitlyn H. McNaughton · 2006 · eCommons (Cornell University)
  37. Targeted therapies for fragile X syndrome: current state and future direction of clinical trials in humans
    Christoph Kamm · 2013 · Clinical Investigation
  38. Molecular Characterisation and Assessment of Clinical Significance of Small Fragile X Alleles
    Mahmoud Shekari Khaniani, Sima Mansoori Derakhshan · 2013 · DOAJ (DOAJ: Directory of Open Access Journals)
  39. Therapiekonzepte bei genetischen Syndromen mit mentaler Retardierung
    Heymut Omran, Jutta Kunde-Trommer, Rainer Blank · 2014 · Elsevier eBooks
  40. Fragile X syndrome, an X-linked dominant disorder with reduced penetrance, is associated with intellectual
    Kathryn B. Garber, Jeannie Visootsak, Stephen T. Warren · 2008
  41. Effects of Sertraline Treatment for Young Children with FXS
    Laura Greiss Hess, Peter Clive Mundy, Randi Jenssen Hagerman · 2015 · Dominican Scholar (Dominican University of California)
  42. Dysregulated ERK signal pathway and immune profiles in Fragile X Syndrome
    Ning Weng · 2012 · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
  43. Die Reaktivierung der FMR1-Transkription in Fibroblasten von Patienten mit Fragilem-X-Syndrom durch Methotrexat
    Jutta Gärtner · 2014
  44. Avances en investigación de la discapacidad intelectual de origen genético: tratamientos experimentales en el síndrome X frágil
    Yolanda de Diego‐Otero, Lucía Pérez-Costillas, Rocío Calvo Medina, Carolina Quintero-Navarro, Isabel del Pino Benítez, Yolanda Casado, Cristina Nogueira Cobas · 2017 · Revista Española de Discapacidad
  45. Genetische Erkrankungen
    2009 · Elsevier eBooks
  46. References
    2010 · Wiley eBooks
  47. Die Reaktivierung der FMR1-Transkription in Fibroblasten von Patienten mit Fragilem-X-Syndrom durch Methotrexat
    Benjamin Mielke · 2014
  48. Fragile X Syndrome
    Randall McCallian, Maria G. Valdovinos · 2011 · Springer eBooks
  49. Fragile X Syndrome
    Elizabeth Berry‐Kravis, Craig A. Erickson · 2024 · Springer eBooks
  50. Pathophysiology of the FMRP-R138Q Fragile X Syndrome missense mutation in mice
    Isabel Chato-Astrain · 2025 · theses.fr (ABES)
  51. Vasopressin 1a Receptor Antagonists for Pathological Aggression in Neurodegenerative and Other CNS Diseases
    Neal G. Simon, Michael Brownstein, Karen Elta Anderson, Shi‐fang Lu, Hilda T. Maibach · 2026 · Biomedicines